Pomalidomide and Baraclude drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pomalidomide (pomalidomide) and Baraclude (entecavir). Common drug interactions include diplopia among females and neutropenia among males.

The phase IV clinical study analyzes what interactions people have when they take Pomalidomide and Baraclude. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Pomalidomide?

Pomalidomide has active ingredients of pomalidomide. eHealthMe is studying from 14,524 Pomalidomide users. Check the latest studies of Pomalidomide.

What is Baraclude?

Baraclude has active ingredients of entecavir. It is often used in hepatitis b. eHealthMe is studying from 6,175 Baraclude users. Check the latest studies of Baraclude.

On Jul, 14, 2026

24 people who take Pomalidomide and Baraclude together, and have interactions are studied.

Pomalidomide and Baraclude drug interactions.

What are the common drug interactions of Pomalidomide and Baraclude, by gender? *:

female:

Diplopia (double vision)
Septic shock (shock due to blood infection)
Vertigo

male:

Neutropenia (an abnormally low number of neutrophils)
Pneumonia
Delirium (wild excitement)
Epistaxis (bleed from the nose)
Haemangioma of skin (noncancerous, abnormally dense collections of dilated small blood vessels that may occur in the skin or internal organs)
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
Hyperkalaemia (damage to or disease of the kidney)
Hypertension (high blood pressure)
Hypervolaemia (abnormally increased volume of blood)
Hypotension (abnormally low blood pressure)

What are the common drug interactions of Pomalidomide and Baraclude, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Sepsis (a severe blood infection that can lead to organ failure and death)

50-59:

Cardiac failure acute
Ejection fraction decreased (systolic heart failure)
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
Pneumonia
Proteinuria (presence of protein in the urine)
Pulmonary alveolar haemorrhage (acute bleeding)
Pyrexia (fever)
Septic shock (shock due to blood infection)

60+:

Neutropenia (an abnormally low number of neutrophils)
Plasma cell myeloma (cancer that begins in plasma cells)
Blood alkaline phosphatase increased
Delirium (wild excitement)
Epistaxis (bleed from the nose)
Haemangioma of skin (noncancerous, abnormally dense collections of dilated small blood vessels that may occur in the skin or internal organs)
Hyperkalaemia (damage to or disease of the kidney)
Hypertension (high blood pressure)
Hypervolaemia (abnormally increased volume of blood)
Hypotension (abnormally low blood pressure)

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 22 people, 91.67%
Hyperlipidaemia (presence of excess lipids in the blood): 4 people, 16.67%
High Blood Pressure: 4 people, 16.67%
Pain: 3 people, 12.50%
Dry Eyes (lack of adequate tears): 3 people, 12.50%
Arrhythmias (irregular heartbeat): 3 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Pomalidomide and Baraclude?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously